ARCHIVES

Cornel Student Withdraws In Wake Of Discrepancies Found In Study

This article is from The Cancer Letter archive.

Vol. 07 No. 38 | September 18, 1981

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

October 31, 2014

New NCI Director Plans Greater Support For Translational Research, Collaboration.

March 1, 2002

NCI Encourages IP Chemo For Stage III Ovarian Cancer

January 27, 2006

NCI-Approved Clinical Trials

July 30, 2004

Study Finds No Link Between Pill And Breast Cancer Risk

July 26, 2002

New Agency To Evaluate PDQ; NCAB Approves NCI Payment Of Part

June 1, 1990